4-(3-(1-benzylpiperidin-4-yl)-5-methyl-2-oxotetrahydropyrimidin-1(2H)-yl)benzimidamide

ID: ALA3780437

Chembl Id: CHEMBL3780437

PubChem CID: 127033248

Max Phase: Preclinical

Molecular Formula: C24H31N5O

Molecular Weight: 405.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1CN(c2ccc(C(=N)N)cc2)C(=O)N(C2CCN(Cc3ccccc3)CC2)C1

Standard InChI:  InChI=1S/C24H31N5O/c1-18-15-28(21-9-7-20(8-10-21)23(25)26)24(30)29(16-18)22-11-13-27(14-12-22)17-19-5-3-2-4-6-19/h2-10,18,22H,11-17H2,1H3,(H3,25,26)

Standard InChI Key:  OOHQSFLVZSYOOH-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3780437

    ---

Associated Targets(Human)

HPN Tchem Serine protease hepsin (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ST14 Tchem Matriptase (677 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HGFAC Tchem Hepatocyte growth factor activator (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRSS1 Tclin Trypsin (2137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.55Molecular Weight (Monoisotopic): 405.2529AlogP: 3.51#Rotatable Bonds: 5
Polar Surface Area: 76.66Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.43CX LogP: 2.23CX LogD: -1.26
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.59Np Likeness Score: -0.93

References

1. Venukadasula PK, Owusu BY, Bansal N, Ross LJ, Hobrath JV, Bao D, Truss JW, Stackhouse M, Messick TE, Klampfer L, Galemmo RA..  (2016)  Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation.,  (2): [PMID:26985294] [10.1021/acsmedchemlett.5b00357]

Source